Drug Profile
Research programme: hearing disorders gene therapy - Akouos
Alternative Names: Anc-80AAVLatest Information Update: 28 May 2023
Price :
$50
*
At a glance
- Originator Akouos
- Class Gene therapies; Nucleic acids
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hearing disorders